Adult congenital heart disease: Looking back, moving forward

Abstract

Advances in congenital heart disease (CHD) have changed radically the prognosis and burden of the disease. The vast majority of patients survive into adulthood and their profile in terms of comorbidities has changed. Organisation of tertiary and non-tertiary care, collaboration at national and international level, randomised controlled trials and implementation of novelties, such as research based biobanking, e-health and artificial intelligence should all be employed to meet their healthcare needs.

Keywords

• Adult congenital heart disease
• Biobanking
• e-health
• Artificial intelligence